Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals (Sagent) is a privately held specialty pharmaceutical company engaged in the development, manufacturing, sourcing and marketing of pharmaceutical products, with a specific emphasis on injectable products. The company owns a unique, global network of resources, that comprises of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, resulting in quick yielding of an extensive portfolio of pharmaceutical products that meets the tailored needs of patients. It has also launched its vinorelbine injection, USP, a anti-mitotic chemotherapy drug, for which the company starts shipping immediately. Sagent comprises of about 200 products in the development stage. Recently, the company entered into an agreement with Actavis Inc., a generic pharmaceutical manufacure company, for the supply of the products in the US market. The company is headquartered at Schaumburg in Illinois, the US.

Street: 
1901 N. Roselle Rd.
City: 
Schaumburg
Postcode: 
60195
Federal State : 
United States
WebSite: 
www.sagentpharma.com
Fax: 
1-847-9081601

Company Index Score

Current Index Score Historical Index Score
  • Sagent Pharmaceuticals, Inc. currently scores 50 % in the index.
  • Sagent Pharmaceuticals, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Sagent Pharmaceuticals, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets